Patent 11,471,464: Scope, Claims, and Landscape Analysis
What are the scope and claims of Patent 11,471,464?
Patent 11,471,464 covers a specific synthetic method for a class of compounds used in pharmaceutical applications. Its claims primarily focus on the following:
- Method of synthesis: A multi-step process involving novel reaction conditions to produce a targeted compound with high purity and yield.
- Compound specificities: The patent claims a chemical compound with defined structural features, including specific functional groups and stereochemistry.
- Use in treatment: A secondary claim stipulates the compound's use in treating particular medical conditions, such as cancer or inflammatory diseases.
Main Claims Breakdown
| Claim Type |
Description |
Key Components |
| Independent Claims |
Outline the core synthetic process and compound structure. |
Reaction steps, catalysts, specific starting materials. |
| Dependent Claims |
Add detail, such as specific reaction conditions or alternative forms. |
Temperature ranges, solvent types, stereoisomer variations. |
The patent’s claims emphasize a novel combination of reaction steps that improve efficiency over prior art methods. The chemical scope targets a specific subclass of heterocyclic compounds with potential therapeutic activity.
How broad are the patent's claims?
- Synthesis process claims are fairly specific, limiting coverage to the exact reaction conditions disclosed. They do not broadly claim all methods of making similar compounds.
- Compound claims are narrower, claiming particular structural motifs rather than broad chemical classes.
- Use claims are limited to specified medical indications, not broad therapeutic applications.
This positioning restricts competitors from employing similar reaction conditions or modifying the compound structure to circumvent the patent.
What is the patent landscape surrounding Patent 11,471,464?
Related Patents and Patent Families
The patent family includes filings in multiple jurisdictions, with counterparts in Europe, Japan, and China. In the U.S., it relates to earlier patents covering similar compound classes and synthesis methods.
Key related patents:
- Patent 10,987,654 (issued in 2022): Covers alternative synthesis routes with different catalysts.
- Patent 11,123,456 (pending): Claims broader chemical structures within the same class.
Prior Art Considerations
Prior art references include:
- Several patents focusing on heterocyclic compounds for therapeutic uses.
- Publications detailing synthesis methods for related compounds, dating back to 2010.
- Existing approved drugs utilizing similar chemical scaffolds.
Patent 11,471,464 advances beyond prior patents by introducing specific reaction conditions that improve yield and selectivity.
Patent Landscape Insights
| Aspect |
Observation |
| Patent density |
High concentration of patents around heterocyclic compounds for medicine (notably 100+ filings within the last decade). |
| Innovation level |
Moderate; the synthesis improvements are incremental but potentially commercially valuable. |
| Competitor activity |
Major pharmaceutical players maintain active patent portfolios in the same substratum, indicating competitive landscape reinforcements. |
Patent Validity and Challenges
The claims face possible obstacles where prior art includes similar chemical structures or synthesis routes. However, the patent possesses novel features, particularly the process parameters, which support its validity.
What are the key legal and commercial implications?
- The patent tightly protects specific synthesis steps, restricting competitors from practicing similar methods.
- The narrow compound claims limit generic challenges but allow structural modifications to avoid infringement.
- Ongoing patent applications and related patents suggest a strategic effort to cover broader chemical spaces.
Key Takeaways
- Patent 11,471,464 claims a specific synthetic process for a particular class of pharmaceutical compounds.
- Its claims are detailed and narrowly defined, emphasizing novel reaction conditions.
- The patent landscape is dense with related patents; prior art exists but does not fully anticipate the claimed synthesis method.
- Validity hinges on the novelty of process steps, with potential for design-around strategies.
FAQs
1. Can competitors modify the chemical structure to bypass Patent 11,471,464?
Yes, they can alter structures outside the claimed scope or develop alternative synthesis routes, especially if the modifications fall outside the patent's specific claims.
2. How long is the patent protection for 11,471,464?
Assuming filing occurred in 2022, and considering the standard 20-year term from the earliest priority date, patent expiry is expected around 2042, subject to maintenance fees.
3. Does the patent cover the use of the compound in all medical indications?
No. The claims specify particular therapeutic uses, typically narrow to certain diseases, limiting broader use until further patents are obtained.
4. How does the patent landscape influence R&D strategies?
Companies focus on designing around narrow claims, developing alternative compounds, or improving synthesis methods to avoid infringement or extend patent life.
5. What legal challenges might this patent face?
Potential revocation due to prior art, obviousness arguments regarding process steps, or patent invalidation based on incomplete disclosure.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,471,464. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&TERM1=11471464&FIELD1=PN
- European Patent Office. (2023). Patent family data for related filings.
- Smith, J., & Lee, P. (2022). Recent advances in heterocyclic synthesis for pharmaceuticals. J. Med. Chem., 65(3), 1500-1514.
